US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist

1.4400
-0.0800-5.26%

Trading Nov 7 14:46 ET

2.08MMarket Cap-164P/E (TTM)

Salarius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-63.05%1.47M

-67.32%1.77M

-43.87%12.89M

-85.02%970.7K

-54.96%2.53M

-16.53%3.97M

-11.39%5.42M

79.31%22.98M

181.08%6.48M

50.06%5.62M

Selling and administrative expenses

-22.63%1.25M

-9.82%1.53M

-19.85%5.72M

-49.18%910.75K

-18.35%1.5M

-11.81%1.62M

1.03%1.7M

16.93%7.14M

23.67%1.79M

5.85%1.83M

-General and administrative expense

-22.63%1.25M

-9.82%1.53M

-19.85%5.72M

-49.18%910.75K

-18.35%1.5M

-11.81%1.62M

1.03%1.7M

16.93%7.14M

23.67%1.79M

5.85%1.83M

Research and development costs

-90.88%214.45K

-93.48%243K

-54.70%7.17M

-98.72%59.95K

-72.66%1.04M

-19.50%2.35M

-16.08%3.73M

85.26%15.84M

73.82%4.69M

88.01%3.79M

Operating profit

63.05%-1.47M

67.32%-1.77M

43.87%-12.89M

85.02%-970.7K

54.96%-2.53M

16.53%-3.97M

11.39%-5.42M

-79.31%-22.98M

-56.29%-6.48M

-50.06%-5.62M

Net non-operating interest income expense

-54.21%43.08K

-29.50%56.33K

61.04%352.25K

-3.88%88.91K

13.69%89.37K

137.42%94.09K

898.13%79.89K

218.73K

92.49K

16,041.07%78.61K

Non-operating interest income

----

-29.50%56.33K

61.04%352.25K

-3.88%88.91K

13.69%89.37K

----

898.13%79.89K

--218.73K

--92.49K

--78.61K

Total other finance cost

54.21%-43.08K

----

-137.42%-94.09K

----

Other net income (expense)

-19,905.01%-8.85M

-63.40%14.45K

-97,817.50%-8.87M

Gain on sale of security

----

-67.66%14.45K

----

Special income (charges)

----

--0

----

---8.87M

--0

---8.87M

-Less:Impairment of capital assets

----

--0

----

--8.87M

--0

--8.87M

Income before tax

63.26%-1.42M

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

Income tax

Net income

63.26%-1.42M

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

Net income continuous Operations

63.26%-1.42M

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

Minority interest income

Net income attributable to the parent company

63.26%-1.42M

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

63.26%-1.42M

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

Basic earnings per share

79.30%-2.37

81.61%-3.28

74.19%-30.72

89.86%-5.2

34.94%-11.45

32.42%-17.84

-92.75%-119.04

-22.22%-22

-206.70%-51.28

Diluted earnings per share

79.30%-2.37

81.61%-3.28

74.19%-30.72

89.86%-5.2

34.94%-11.45

32.42%-17.84

-92.75%-119.04

-22.22%-22

-206.70%-51.28

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-63.05%1.47M	-67.32%1.77M	-43.87%12.89M	-85.02%970.7K	-54.96%2.53M	-16.53%3.97M	-11.39%5.42M	79.31%22.98M	181.08%6.48M	50.06%5.62M
Selling and administrative expenses	-22.63%1.25M	-9.82%1.53M	-19.85%5.72M	-49.18%910.75K	-18.35%1.5M	-11.81%1.62M	1.03%1.7M	16.93%7.14M	23.67%1.79M	5.85%1.83M
-General and administrative expense	-22.63%1.25M	-9.82%1.53M	-19.85%5.72M	-49.18%910.75K	-18.35%1.5M	-11.81%1.62M	1.03%1.7M	16.93%7.14M	23.67%1.79M	5.85%1.83M
Research and development costs	-90.88%214.45K	-93.48%243K	-54.70%7.17M	-98.72%59.95K	-72.66%1.04M	-19.50%2.35M	-16.08%3.73M	85.26%15.84M	73.82%4.69M	88.01%3.79M
Operating profit	63.05%-1.47M	67.32%-1.77M	43.87%-12.89M	85.02%-970.7K	54.96%-2.53M	16.53%-3.97M	11.39%-5.42M	-79.31%-22.98M	-56.29%-6.48M	-50.06%-5.62M
Net non-operating interest income expense	-54.21%43.08K	-29.50%56.33K	61.04%352.25K	-3.88%88.91K	13.69%89.37K	137.42%94.09K	898.13%79.89K	218.73K	92.49K	16,041.07%78.61K
Non-operating interest income	----	-29.50%56.33K	61.04%352.25K	-3.88%88.91K	13.69%89.37K	----	898.13%79.89K	--218.73K	--92.49K	--78.61K
Total other finance cost	54.21%-43.08K	----	----	----	----	-137.42%-94.09K	----	----	----	----
Other net income (expense)								-19,905.01%-8.85M	-63.40%14.45K	-97,817.50%-8.87M
Gain on sale of security	----	----	----	----	----	----	----	-67.66%14.45K	----	----
Special income (charges)	----	----	--0	--0	--0	----	----	---8.87M	--0	---8.87M
-Less:Impairment of capital assets	----	----	--0	--0	--0	----	----	--8.87M	--0	--8.87M
Income before tax	63.26%-1.42M	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M
Income tax
Net income	63.26%-1.42M	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M
Net income continuous Operations	63.26%-1.42M	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M
Minority interest income
Net income attributable to the parent company	63.26%-1.42M	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	63.26%-1.42M	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M
Basic earnings per share	79.30%-2.37	81.61%-3.28	74.19%-30.72	0	89.86%-5.2	34.94%-11.45	32.42%-17.84	-92.75%-119.04	-22.22%-22	-206.70%-51.28
Diluted earnings per share	79.30%-2.37	81.61%-3.28	74.19%-30.72	0	89.86%-5.2	34.94%-11.45	32.42%-17.84	-92.75%-119.04	-22.22%-22	-206.70%-51.28
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data